首页> 外文期刊>Food and Nutrition Sciences >Individual and Combined Effects of Nucleotides and Human Milk Oligosaccharides on Proliferation, Apoptosis and Necrosis in a Human Fetal Intestinal Cell Line
【24h】

Individual and Combined Effects of Nucleotides and Human Milk Oligosaccharides on Proliferation, Apoptosis and Necrosis in a Human Fetal Intestinal Cell Line

机译:核苷酸和人乳寡糖对人胎肠道细胞系增殖,凋亡和坏死的单独和联合作用

获取原文
           

摘要

Nucleotides (NT) and human milk oligosaccharides (HMO) individually affect epithelial cell growth, but their combined effects had not been studied. Herein, the impact of NT and HMO on cell proliferation, apoptosis, necrosis and cell cycle in the fetal epithelial cell line (FHs-74 Int) was determined. Cells were incubated with media containing 2.5% FBS and no epidermal growth factor (Control); fucosyllactose (FL) mix [85% 2’FL/15% 3’FL], sialyllactose (SL) mix [40% 6’SL/10% 3’SL/50% sialic acid (SA)] or LNnT at 125, 250, 500 or 1000 μg/mL with and without 250 μg/mL NT (43% CMP, 18.5% UMP, 16.4% AMP, and 22.0% GMP) for 24 or 72 h. NT alone significantly increased proliferation, but did not affect cell cycle or apoptosisecrosis. All HMO treatments at 1000 μg/mL significantly decreased proliferation and some were also inhibitory at 250 or 500 μg/mL. When NT and HMO were simultaneously added, NT ameliorated the anti-proliferative effect of HMO. FL significantly increased cells in S phase and SL and LNnT treatments significantly increased cells in G2/M and S phases, which concomitantly decreased cells in G0/G1. HMO with NT significantly decreased the percent of cells in the G2/M phase compared to HMO alone. Higher HMO doses significantly increased the percentage of apoptotic and necrotic cells compared to control. In conclusion, HMO reduced cell proliferation and this effect is partially ameliorated by NT. It appears that HMO initially induced apoptosisecrosis, which was later evidenced by G2/M cell cycle arrest and decreased proliferation.
机译:核苷酸(NT)和人乳寡糖(HMO)分别影响上皮细胞的生长,但尚未研究它们的联合作用。本文中,确定了NT和HMO对胎儿上皮细胞系(FHs-74 Int)中细胞增殖,凋亡,坏死和细胞周期的影响。细胞与含有2.5%FBS且无表皮生长因子的培养基一起孵育(对照);岩藻糖半乳糖(FL)混合物[85%2'FL / 15%3'FL],唾液乳糖(SL)混合物[40%6'SL / 10%3'SL / 50%唾液酸(SA)]或LNnT在125, 250、500或1000μg/ mL,含和不含250μg/ mL NT(43%CMP,18.5%UMP,16.4%AMP和22.0%GMP)持续24或72 h。单独的NT显着增加增殖,但不影响细胞周期或凋亡/坏死。所有浓度为1000μg/ mL的HMO处理均会显着降低增殖,有些还抑制了250或500μg/ mL。当同时加入NT和HMO时,NT改善了HMO的抗增殖作用。 FL显着增加了S期的细胞,而SL和LNnT处理显着增加了G2 / M和S期的细胞,从而减少了G0 / G1中的细胞。与单独的HMO相比,带有NT的HMO显着降低了G2 / M期细胞的百分比。与对照相比,较高的HMO剂量显着增加了凋亡和坏死细胞的百分比。总之,HMO减少了细胞增殖,NT可以部分改善这种作用。似乎HMO最初诱导细胞凋亡/坏死,后来被G2 / M细胞周期停滞和增殖减少所证明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号